Treatment of epilepsy in the multiply handicapped.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Mental Retardation and Developmental Disabilities Research Reviews

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1098-2779(2000)6:4<309::AID-MRDD10>3.0.CO;2-IPMID 11107196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disposition of the antiepileptic oxcarbazepine and its metabolites in healthy volunteers

  2004cited by this paper
• The effect of tiagabine on spasticity in children with intractable epilepsy: a pilot study.

  1999cited by this paper
• Hippocampal and Entorhinal Cortex High‐Frequency Oscillations (100–500 Hz) in Human Epileptic Brain and in Kainic Acid‐Treated Rats with Chronic Seizures

  1999cited by this paper
• Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV).

  1999cited by this paper
• Lamotrigine‐Associated Rash: Risk/Benefit Considerations in Adults and Children

  1999cited by this paper
• A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures

  1999cited by this paper
• Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial.

  1999cited by this paper
• Treatment of infantile spasms with zonisamide.

  1999cited by this paper
• Topiramate Pharmacokinetics in Infants

  1999cited by this paper
• Evidence‐based Medicine and Antiepileptic Drugs

  1999cited by this paper
• Topiramate and Metabolic Acidosis

  1999cited by this paper
• Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children

  1998cited by this paper
• Treating repetitive seizures with a rectal diazepam formulation

  1998cited by this paper
• Vigabatrin-associated retinal cone system dysfunction

  1998cited by this paper
• Topical Review: Use of Midazolam for Refractory Status Epilepticus in Pediatric Patients

  1998cited by this paper
• Management of Acute Seizure Episodes

  1998cited by this paper
• Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

  1998cited by this paper
• A Pilot Study of Topiramate in the Treatment of Infantile Spasms

  1998cited by this paper
• Generalized Tonic Seizures Induced by a Unilateral Microinjection of Kainic Acid into the Pontine Reticular Formation in Rats

  1998cited by this paper
• A summary of mechanistic hypotheses of gabapentin pharmacology.

  1998cited by this paper
• Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy

  1998cited by this paper
• The Efficacy of Lamotrigine in Children and Adolescents with Refractory Generalized Epilepsy: A Randomized, Double‐Blind, Crossover Study

  1998cited by this paper
• Safety of high intravenous valproate loading doses in epilepsy patients

  1998cited by this paper
• Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients.

  1998cited by this paper
• Treatment of Refractory Status Epilepticus with Propofol: Clinical and Pharmacokinetic Findings

  1998cited by this paper
• A comparison of rectal diazepam gel and placebo for acute repetitive seizures.

  1998cited by this paper
• Long-term safety and efficacy of lamotrigine (Lamictal) in paediatric patients with epilepsy.

  1997cited by this paper
• Preliminary Observations on Topiramate in Pediatric Epilepsies

  1997cited by this paper
• In Whom Does Status Epilepticus Occur: Age‐Related Differences in Children

  1997cited by this paper
• Evaluation of Case Reports of Aplastic Anemia Among Patients Treated with Felbamate

  1997cited by this paper
• New and Developing MRI Techniques in Epilepsy

  1997cited by this paper
• Clinical Efficacy of Topiramate as Add‐On Therapy in Refractory Partial Epilepsy: The European Experience

  1997cited by this paper
• Efficacy of Topiramate as Adjunctive Therapy in Refractory Partial Seizures: United States Trial Experience

  1997cited by this paper
• Topiramate Monotherapy for Partial Onset Seizures

  1997cited by this paper
• Imaging in the Investigation Strategy of Presurgical Patients

  1997cited by this paper
• Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group.

  1997cited by this paper
• Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.

  1997cited by this paper
• Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.

  1997cited by this paper
• A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children

  1997cited by this paper
• Severe persistent visual field constriction associated with vigabatrin

  1997cited by this paper
• Oxcarbazepine in the Treatment of Early Childhood Epilepsy

  1997cited by this paper
• Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome.

  1997cited by this paper
• Felbamate.

  1997cited by this paper
• Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.

  1997cited by this paper
• Nasal benzodiazepines for management of acute childhood seizures?

  1997cited by this paper
• Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group.

  1997cited by this paper
• Gabapentin monotherapy: I. An 8-day, double-blind, dose controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures

  1997cited by this paper
• New antiepileptic drugs in children: present and future.

  1997cited by this paper
• Treatment With High Doses of Lamotrigine in Children and Adolescents With Refractory Seizures

  1997cited by this paper
• Long‐Term Experience with Topiramate as Adjunctive Therapy and as Monotherapy in Patients with Partial Onset Seizures: Retrospective Survey of Open‐Label Treatment

  1997cited by this paper
• A single‐dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures

  1997cited by this paper
• Lamotrigine Adjunctive Therapy in Childhood Epileptic Encephalopathy (the Lennox Gastaut Syndrome)

  1997cited by this paper
• Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures

  1997cited by this paper
• Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

  1997cited by this paper
• Overview of Lamotrigine and the New Antiepileptic Drugs: The Challenge

  1997cited by this paper
• Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy.

  1996cited by this paper
• Efficacy of gabapentin therapy in children with refractory partial seizures.

  1996cited by this paper
• Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study.

  1996cited by this paper
• Gabapentin Associated with Aggressive Behavior in Pediatric Patients with Seizures

  1996cited by this paper
• Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures

  1996cited by this paper
• Valproic acid hepatic fatalities. III. U.S. experience since 1986

  1996cited by this paper
• Frontolimbic Dysfunction as a Pathogenetic Mechanism of Autism: Localization of Paroxysmal Abnormality in the Magnetoencephalogram.

  1996cited by this paper
• New drugs for the treatment of epilepsy.

  1996cited by this paper
• Tiagabine and non-convulsive status epilepticus.

  1996cited by this paper
• Combination vigabatrin and lamotrigine therapy for intractable epilepsy.

  1996cited by this paper
• Lamotrigine: clinical experience in 200 patients with epilepsy with follow-up to four years

  1996cited by this paper
• Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages

  1996cited by this paper
• Lamotrigine-induced rash in children

  1996cited by this paper
• Behavioral Side Effects of Gabapentin in Children

  1996cited by this paper
• Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages

  1996cited by this paper
• Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy

  1996cited by this paper
• Controlled trial of lamotrigine (Lamictal®) for treatment‐resistant partial seizures

  1996cited by this paper
• A double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizures

  1996cited by this paper
• A decade of modern epilepsy therapy in institutionalized mentally retarded patients.

  1996cited by this paper
• A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy.

  1996cited by this paper
• Lamotrigine as an add‐on drug in typical absence seizures

  1995cited by this paper
• Vigabatrin in Childhood Epilepsy: A 5-Year Follow-Up Study

  1995cited by this paper
• Lamotrigine for the treatment of epilepsy in childhood.

  1995cited by this paper
• Gabapentin Toxicity in Children Manifesting as Behavioral Changes

  1995cited by this paper
• The management of epilepsy in children: the role of the clinical nurse specialist.

  1995cited by this paper
• Vigabatrin in the management of generalized seizures in children.

  1995cited by this paper
• The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability.

  1995cited by this paper
• Successful Epilepsy Surgery Without Intracranial EEG Recording: Criteria for Patient Selection

  1995cited by this paper
• Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy : a randomized, controlled study

  1995cited by this paper
• Tiagabine Pharmacology in Profile

  1995cited by this paper
• Lamotrigine: clinical experience in 93 patients with epilepsy

  1995cited by this paper
• Tiagabine Monotherapy in the Treatment of Partial Epilepsy

  1995cited by this paper
• Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.

  1995cited by this paper
• Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.

  1995cited by this paper
• Messages of Support

  1995cited by this paper
• Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study.

  1995cited by this paper
• Mechanism of action of the anticonvulsant felbamate: Opposing effects on N‐methyl‐D‐aspartate and γ‐aminobutyric acidA receptors

  1994cited by this paper
• Long-term study with gabapentin in patients with drug-resistant epileptic seizures.

  1994cited by this paper
• Syndromic Classification in the Management of Childhood Epilepsy

  1994cited by this paper
• Intractable Epilepsy in Children. The Efficacy of Lamotrigine Treatment, Including Non-Seizure-Related Benefits

  1994cited by this paper
• Lamotrigine in infantile spasms.

  1994cited by this paper
• Gabapentin (Neurontin) as Add‐on Therapy in Patients with Partial Seizures: A Double‐Blind, Placebo‐Controlled Study

  1994cited by this paper
• New Anticonvulsant Drugs

  1994cited by this paper
• Antiepileptic Drugs in Development: Prospects for the Near Future

  1994cited by this paper
• Lamotrigine Therapy for Partial Seizures: A Multicenter, Placebo‐Controlled, Double‐Blind, Cross‐Over Trial

  1994cited by this paper

• Status Epilepticus a risk factor for Sudden Unexpected Death in Epilepsy (SUDEP): A scoping review and narrative synthesis.

  2024cites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  2023cites this paper
• Outpatient vagus nerve stimulation surgery in patients with drug-resistant epilepsy with severe intellectual disability.

  2021cites this paper
• Long‐term effects of zonisamide in adult patients with intellectual disability

  2021cites this paper
• Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study.

  2019cites this paper
• Épilepsie et polyhandicap chez l’enfant : mise au point de la Commission « handicap » de la Société française de neurologie pédiatrique

  2019cites this paper
• Intellectual Disability and Epilepsy

  2018cites this paper
• Epilepsy in People with Intellectual Disabilities

  2018cites this paper
• Clinical utility of topiramate extended-release capsules (USL255): Bioequivalence of USL255 sprinkled and intact capsule in healthy adults and an in vitro evaluation of sprinkle delivery via enteral feeding tubes.

  2016cites this paper
• Epilepsy and Intellectual Disabilities

  2016cites this paper
• Treatment non-adherence as a trigger for status epilepticus: An observational, retrospective study based on therapeutic drug monitoring.

  2015cites this paper
• 重度精神遅滞児 (者) の行動障害に対するlamotrigineの効果の検討

  2015cites this paper
• USL255 extended-release topiramate for the treatment of epilepsy

  2014cites this paper
• A White Paper on the medical and social needs of people with epilepsy and intellectual disability: The Task Force on Intellectual Disabilities and Epilepsy of the International League Against Epilepsy

  2014cites this paper
• A qualitative study of carers' and professionals' views on the management of people with intellectual disability and epilepsy: a neglected population.

  2013cites this paper
• Community perspectives on vitamin D and bone health in three at-risk populations.

  2013cites this paper
• A Practitioner’s Guide to Prescribing Felbamate for Adults with Intellectual Disabilities

  2012cites this paper
• 重症心身障害児 (者) の難治てんかん治療におけるlamotrigineの特性

  2012cites this paper
• A Practitioner’s Guide to Prescribing Primidone for Adults with Intellectual Disabilities

  2012cites this paper
• A comparison of antiepileptic drug therapy in patients with severe intellectual disability and patients with normal intellect.

  2012cites this paper
• A Practitioner’s Guide to Prescribing Phenobarbital for Adults with Intellectual Disabilities

  2012cites this paper
• Topiramate-induced weight loss: a review.

  2011cites this paper
• Recurrent seizure-related injuries in people with epilepsy at a tertiary epilepsy center: a 2-year longitudinal study.

  2010cites this paper
• Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy.

  2009cites this paper
• Neurological comorbidity and epilepsy: implications for treatment

  2009cites this paper
• Topiramate in patients with epilepsy and intellectual disability.

  2009cites this paper
• Management of Acute Seizures in Persons with Intellectual Disabilities

  2008cites this paper
• Children with learning disabilities

  2008cites this paper
• Health Care Transition for Youth with Cerebral Palsy

  2008cites this paper
• Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation*

  2006cites this paper
• Optimizing therapy of seizures in children and adolescents with developmental disabilities

  2006cites this paper
• Adjunctive Lamotrigine for Refractory Epilepsy in Adolescents with Mental Retardation

  2006cites this paper
• Vagus nerve stimulation therapy: 2-year prospective open-label study of 40 subjects with refractory epilepsy and low IQ who are living in long-term care facilities.

  2005cites this paper
• Managing Behavioral and Cognitive Problems in Children With Epilepsy

  2004cites this paper
• Defining the problem: psychiatric and behavioral comorbidity in children and adolescents with epilepsy.

  2004cites this paper
• Impact of new-generation agents on antiepileptic drug prescribing patterns in a residential ICF-MR facility.

  2004cites this paper
• Management of Epilepsy in Mentally Retarded Children Using the Newer Antiepileptic Drugs, Vagus Nerve Stimulation, and Surgery

  2004cites this paper
• Epilepsy and Developmental Disability Part I : Developmental Disorders in Which Epilepsy May be Comorbid

  2004cites this paper
• Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients

  2004cites this paper
• Learning disability.

  2003cites this paper
• Effect of Antiepileptic Drugs on Bodyweight

  2003cites this paper
• Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.

  2003cites this paper
• Antiepileptic drugs in children with developmental delays and behavioral problems

  2003cites this paper
• What Do You Do When They Grow Up? Approaches to Seizures in Developmentally Delayed Adults

  2002cites this paper
• Topiramate and Weight Loss in Patients with Neurodevelopmental Disabilities

  2002cites this paper
• Selective Blockade of N‐Type Calcium Channels by Levetiracetam

  2002cites this paper
• Treatment considerations: traditional antiepileptic drugs.

  2002cites this paper
• Topiramate in Patients with Learning Disability and Refractory Epilepsy

  2002cites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper
• Outpatient vagus nerve stimulation surgery in drug-resistant epilepsy patients with severe intellectual disability

  year unknowncites this paper